ILDR1 Activators
ILDR1 activators encompass a group of chemical compounds that influence various biochemical and cellular pathways, which can indirectly lead to the enhanced activity of ILDR1. These compounds include activators of adenyILDR1 activators encompass a group of chemical compounds that influence various biochemical and cellular pathways, which can indirectly lead to the enhanced activity of ILDR1. These compounds include activators of adenylate cyclase such as Forskolin, which elevates cAMP levels, thereby enhancing ILDR1 function through cAMP-dependent protein kinase (PKA) pathways. PKA, upon activation, can phosphorylate a broad range of substrates, leading to alterations in cellular functions and protein interactions that could enhance ILDR1's activity if it is regulated by PKA-mediated phosphorylation. Furthermore, compounds like IBMX raise intracellular cAMP and cGMP by inhibiting phosphodiesterases, which may augment PKA or PKG activity and subsequently affect ILDR1 function.
Additionally, epidermal growth factor (EGF) can activate its receptor, triggering the MAPK/ERK signaling cascade. This pathway leads to the phosphorylation of various proteins, which might include those that interact with or regulate ILDR1, thereby enhancing its activity. Phorbol esters like PMA directly activate protein kinase C (PKC), which phosphorylates numerous substrates and could modulate ILDR1 activity through alterations in protein interactions. Calcium signaling modulators such as Ionomycin can increase intracellular calcium levels impacting ILDR1 activity either directly, if ILDR1 is a calcium-dependent protein, or indirectly through calcium-activated signaling proteins. Inhibitors of protein tyrosine phosphatases like Sodium Orthovanadate may increase the phosphorylation state of proteins within ILDR1-related pathways, enhancing its functional activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP can activate PKA, which in turn can phosphorylate proteins and modify their activity. Phosphorylation of target proteins by PKA can enhance ILDR1 function if ILDR1 activity is regulated by phosphorylation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, enzymes that break down cAMP and cGMP. By inhibiting these enzymes, IBMX can raise the levels of these cyclic nucleotides, potentially enhancing the activity of PKA or PKG, which may then modulate the activity of ILDR1 if it is subject to regulation by phosphorylation by these kinases. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a variety of proteins. Activation of PKC can lead to changes in protein interactions and activities, potentially including those that modulate ILDR1 function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin and calcium-dependent protein kinases, which may influence the activity of ILDR1 directly if it is a substrate for these kinases, or indirectly by modifying the activity of proteins that regulate ILDR1. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is an inhibitor of protein tyrosine phosphatases. Inhibition of these phosphatases can lead to increased levels of phosphorylated proteins, potentially enhancing the activity of proteins in pathways that regulate ILDR1 function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a specific inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A), leading to increased phosphorylation levels of cellular proteins. This can indirectly enhance the function of ILDR1 if the protein's activity is regulated by phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3 kinase inhibitor, which can modulate the PI3K/Akt pathway. By inhibiting this pathway, there may be alterations in downstream signaling that could indirectly enhance ILDR1 activity if ILDR1 is part of signaling complexes affected by PI3K/Akt activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase, which is involved in cellular stress responses. Inhibition of p38 MAPK can lead to altered signaling dynamics in pathways that may intersect with those regulating ILDR1, potentially enhancing its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which acts upstream of ERK in the MAPK pathway. Inhibition of MEK may lead to alterations in the MAPK pathway, potentially affecting proteins that regulate ILDR1 activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor, which may block phosphorylation events that regulate the activity of proteins involved in signaling pathways that intersect with those regulating ILDR1, potentially enhancing its activity. | ||||||